Trial | NCT00351806  Report issue

Title

AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine
AISTCM-The Pathological Pattern Differentiation and Outcome Measurement of Acute Ischemic Stroke Treated With Traditional Chinese Medicine

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    500
The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and to observe its safety.
The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and safety.
Study Started
Jul 31
2005
Study Completion
Nov 30
2006
Last Update
Aug 07
2013
Estimate

Drug Erigeron breviscapus injection

Drug hua tuo zai zao wan (a herbal medicine pill)

Drug Compound stroke herbal medicine (8 herbal)

Chinese herbal medicine Experimental

placebo Placebo Comparator

Criteria 

Inclusion Criteria:

Ischemic stroke diagnosis by CT/MRI scan
Yin pattern of Traditional Chinese Medicine Theory
40-85 years old
Total anterior circulation infarcts (TACI), partial anterior territory cerebral infarction (PACI), lacunar anterior circulation infarcts (LACI) type under Oxfordshire Community Stroke Project (OCSP) standard
NIHSS >=4;
Glasgow coma scale (GCS) >=7;
Modified Rankin Scale less than 2 degrees before onset of this stroke
Informed consent signed by patient or his/her family

Exclusion Criteria:

Hemorrhagic stroke;
Coma, GCS<=7;
Cerebral hernia;
Serious heart, liver, lung, kidney functional failure;
Gastrointestinal (GI) bleeding;
Thrombolysis drugs or surgery was administrated to the patient;
Not cooperative with physician;
Psychological disorder;
Already taken part in other clinical drug trial within the past 3 months
No Results Posted